pyrazines has been researched along with Pancreatitis in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (5.71) | 18.2507 |
| 2000's | 2 (5.71) | 29.6817 |
| 2010's | 30 (85.71) | 24.3611 |
| 2020's | 1 (2.86) | 2.80 |
| Authors | Studies |
|---|---|
| Liddle, RA; Liedtke, W; Pandol, SJ; Romac, JM; Shahid, RA; Swain, SM; Vigna, SR | 1 |
| Li, J; Li, ZF; Zhang, J; Zhang, S; Zhou, R | 1 |
| Chen, L; Chen, Y; Jianli, Z; Yun, H | 1 |
| Chang, HY; Clark, JM; Richards, TM; Segal, JB; Singh, S; Weiner, JP | 1 |
| Gale, EA | 1 |
| Cohen, D | 2 |
| Drake, AJ; Iyer, SN; Mendez, CE; Tanenberg, RJ; West, RL | 1 |
| Aston-Mourney, K; Goldstein, LC; Hull, RL; Meier, DT; Samarasekera, T; Subramanian, SL; Zraika, S | 1 |
| Li, J; Liu, SS; Tsui, J; Wang, HH; Wang, XY | 1 |
| Harja, E; Lord, J; Skyler, JS | 1 |
| Akar, M; Aktan Kosker, T; Buyukasik, S; Ersoy, O; Solakoglu, T | 1 |
| Rouse, R; Stewart, S; Xu, L; Zhang, J | 1 |
| Ashikaga, T; Keino, D; Kinoshita, A; Kondoh, K; Morimoto, M; Ohyama, R; Yamashita, A | 1 |
| Duke, J; Li, X; Zhang, Z | 1 |
| Nandith, A; Ramachandran, A; Shetty, AS; Snehalath, C | 1 |
| Cao, W; Chen, J; Cui, M; Shi, Q; Wang, C; Wang, X; Zhang, B; Zhang, G; Zhao, Y | 1 |
| Arnold Chan, K; Dore, DD; Seeger, JD | 1 |
| Biczó, G; Halm, G; Rakonczay, Z; Szabolcs, A; Takács, T; Tiszlavicz, L; Wittmann, T | 1 |
| Dong, X; Gao, SL; Jiang, RY; Peng, JP; Wang, J; Wu, YL; Xie, QP; Zhan, YC | 1 |
| Clay, RJ; Engel, SS; Goldstein, BJ; Golm, GT; Kaufman, KD; Machotka, SV; Williams-Herman, DE | 1 |
| Ben Salem, C; Biour, M; Bouraoui, K; Elouni, B; Sakhri, J; Zamy, M | 1 |
| Garg, R; Hussey, C; Ibrahim, S | 1 |
| Chen, W; Garg, R; Pendergrass, M | 1 |
| Khosroshahi, A; Stone, JH | 1 |
| Ma, ML; Ou, JM; Wang, C; Wu, DJ; Zhang, XP | 1 |
| Butler, PC; Elashoff, M; Elashoff, R; Gier, B; Matveyenko, AV | 1 |
| Hawkes, N | 1 |
| Gundert-Remy, U; Spranger, J; Stammschulte, T | 1 |
| Niessen, M; Spinas, GA; Xu, L | 1 |
| Masmiquel Comas, L; Nicolau Ramis, J | 1 |
| Inaba, H; Kishimoto, W; Nakano, M; Nakao, A; Takagi, H; Takahashi, A | 1 |
| Wang, XP; Xu, JY; Yuan, YZ | 1 |
4 review(s) available for pyrazines and Pancreatitis
| Article | Year |
|---|---|
Perspectives of traditional Chinese medicine in pancreas protection for acute pancreatitis.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Apigenin; Artemisinins; Drugs, Chinese Herbal; Emodin; Flavanones; Glucuronates; Humans; Medicine, Chinese Traditional; Pancreas; Pancreatitis; Patient Safety; Phytotherapy; Plant Extracts; Pyrazines; Resveratrol; Rheum; Salvia miltiorrhiza; Stilbenes; Sulfates | 2017 |
[Efficacy of chemotherapy combined with bortezomib for two cases of relapsed/refractory acute lymphoblastic leukemia].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Doxorubicin; Fatal Outcome; Female; Humans; Lung Diseases, Interstitial; Octreotide; Pancreatitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteasome Inhibitors; Pyrazines; Recurrence; Salvage Therapy; Treatment Outcome; Vincristine | 2014 |
Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis.
Topics: Acute Disease; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Pancreatitis; Pyrazines; Randomized Controlled Trials as Topic; Risk Factors; Sitagliptin Phosphate; Triazoles | 2010 |
Treatment approaches to IgG4-related systemic disease.
Topics: Antibodies, Monoclonal, Murine-Derived; Autoimmune Diseases; Boronic Acids; Bortezomib; Glucocorticoids; Humans; Immunoglobulin G; Immunosuppressive Agents; Pancreatitis; Prognosis; Pyrazines; Recurrence; Rituximab | 2011 |
31 other study(ies) available for pyrazines and Pancreatitis
| Article | Year |
|---|---|
TRPV4 channel opening mediates pressure-induced pancreatitis initiated by Piezo1 activation.
Topics: Acinar Cells; Animals; Calcium; Calcium Signaling; Cell Death; Disease Models, Animal; Female; Ion Channels; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Biological; Pancreas; Pancreatitis; Pressure; Pyrazines; Thiadiazoles; TRPV Cation Channels | 2020 |
Tetramethylpyrazine (TMP) protects rats against acute pancreatitis through NF-κB pathway.
Topics: Acute Disease; Animals; Apoptosis; Cytokines; Interleukin-6; Male; Mice; NF-kappa B; Pancreatitis; Pyrazines; Rats; Signal Transduction; Tumor Necrosis Factor-alpha | 2019 |
Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study.
Topics: Acute Disease; Adolescent; Adult; Case-Control Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Female; Glucagon-Like Peptide 1; Hospitalization; Humans; Logistic Models; Male; Middle Aged; Pancreatitis; Peptides; Pyrazines; Risk Factors; Sitagliptin Phosphate; Triazoles; Venoms | 2013 |
GLP-1 based agents and acute pancreatitis : drug safety falls victim to the three monkey paradigm.
Topics: Acute Disease; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Incretins; Metaphor; Pancreatitis; Peptides; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Venoms | 2013 |
Two drugs for type 2 diabetes seem to raise risk of acute pancreatitis, study shows.
Topics: Acute Disease; Animals; Diabetes Mellitus, Type 2; Evidence-Based Medicine; Exenatide; Humans; Hypoglycemic Agents; Pancreatitis; Peptides; Pyrazines; Risk Assessment; Risk Factors; Sitagliptin Phosphate; Triazoles; Venoms | 2013 |
Pancreatitis associated with incretin-based therapies.
Topics: Diabetes Mellitus, Type 2; Exenatide; Humans; Hypoglycemic Agents; Incretins; Pancreatitis; Peptides; Pyrazines; Sitagliptin Phosphate; Triazoles; Venoms | 2013 |
Reports of pancreatitis are 20-30 times more likely with GLP-1 drugs, analysis finds.
Topics: Adamantane; Diabetes Mellitus; Dipeptides; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Linagliptin; Pancreatitis; Purines; Pyrazines; Quinazolines; Sitagliptin Phosphate; Triazoles; United States | 2013 |
One year of sitagliptin treatment protects against islet amyloid-associated β-cell loss and does not induce pancreatitis or pancreatic neoplasia in mice.
Topics: Animals; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Hemizygote; Humans; Hypoglycemic Agents; Insulin-Secreting Cells; Islet Amyloid Polypeptide; Male; Metformin; Mice; Mice, Transgenic; Pancreas; Pancreatic Neoplasms; Pancreatitis; Plaque, Amyloid; Pyrazines; Random Allocation; Recombinant Proteins; Sitagliptin Phosphate; Time Factors; Triazoles | 2013 |
Bortezomib-induced acute pancreatitis in a patient with multiple myeloma.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Female; Humans; Middle Aged; Multiple Myeloma; Pancreatitis; Pyrazines; Tomography, X-Ray Computed | 2014 |
An analysis of characteristics of subjects examined for incretin effects on pancreatic pathology.
Topics: Adolescent; Adult; Aged; Databases, Factual; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Exenatide; Female; Glucagon-Like Peptide-1 Receptor; Humans; Hyperplasia; Hypoglycemic Agents; Incretins; Male; Middle Aged; Models, Statistical; Pancreas; Pancreatitis; Peptides; Pyrazines; Receptors, Glucagon; Sitagliptin Phosphate; Tissue Banks; Triazoles; Venoms; Young Adult | 2013 |
Is bortezomib a rare cause of acute pancreatitis?
Topics: Abdominal Pain; Acute Disease; Antineoplastic Agents; Boronic Acids; Bortezomib; Humans; Male; Middle Aged; Multiple Myeloma; Pancreatitis; Pyrazines | 2013 |
High fat diet and GLP-1 drugs induce pancreatic injury in mice.
Topics: Acute Disease; Animals; Apoptosis; Atrophy; Diet, High-Fat; Exenatide; Glucagon-Like Peptide-1 Receptor; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Necrosis; Pancreas; Pancreatitis; Peptides; Pyrazines; Receptors, Glucagon; Sitagliptin Phosphate; Triazoles; Venoms | 2014 |
Glucagon-like peptide 1-based therapies and risk of pancreatitis: a self-controlled case series analysis.
Topics: Adult; Aged; Cohort Studies; Databases, Factual; Exenatide; Female; Glucagon-Like Peptide 1; Humans; Male; Middle Aged; Pancreatitis; Peptides; Pyrazines; Risk Factors; Sitagliptin Phosphate; Triazoles; Venoms; Young Adult | 2014 |
Treatment with DPP-4 inhibitors does not increase the chance of pancreatitis in patients with type 2 diabetes.
Topics: Adult; Aged; Amylases; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipase; Male; Middle Aged; Pancreatitis; Pyrazines; Retrospective Studies; Risk Assessment; Sitagliptin Phosphate; Triazoles | 2013 |
Ligustrazine alleviates acute pancreatitis by accelerating acinar cell apoptosis at early phase via the suppression of p38 and Erk MAPK pathways.
Topics: Acinar Cells; Acute Disease; Amylases; Animals; Apoptosis; Cell Line; Cytokines; Disease Models, Animal; Down-Regulation; Inflammation Mediators; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Pancreatitis; Peroxidase; Phosphorylation; Pyrazines; Rats, Sprague-Dawley | 2016 |
Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide.
Topics: Adolescent; Adult; Databases, Factual; Exenatide; Female; Glyburide; Humans; Hypoglycemic Agents; Insurance, Health; Male; Metformin; Middle Aged; Pancreatitis; Peptides; Pyrazines; Risk Assessment; Safety; Sitagliptin Phosphate; Triazoles; United States; Venoms; Young Adult | 2009 |
Simultaneous proteosome inhibition and heat shock protein induction by bortezomib is beneficial in experimental pancreatitis.
Topics: Animals; Boronic Acids; Bortezomib; Heat-Shock Proteins; Male; Multienzyme Complexes; Pancreas; Pancreatitis; Protease Inhibitors; Pyrazines; Rats; Rats, Wistar | 2009 |
The potential effect of proteasome inhibitor PS-341 on severe acute pancreatitis detected by positron emission tomography in ICR mice.
Topics: Amylases; Animals; Apoptosis; Boronic Acids; Bortezomib; C-Reactive Protein; Ceruletide; Female; Inflammation; Interleukin-1beta; L-Lactate Dehydrogenase; Mice; Mice, Inbred ICR; Pancreatitis; Positron-Emission Tomography; Protease Inhibitors; Pyrazines; Radiography | 2010 |
Bortezomib-induced acute pancreatitis.
Topics: Acute Disease; Antineoplastic Agents; Boronic Acids; Bortezomib; Female; Humans; Middle Aged; Multiple Myeloma; Pancreatitis; Pyrazines | 2010 |
Pancreatitis associated with the use of sitagliptin and orlistat combination: a case report.
Topics: Anti-Obesity Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Lactones; Middle Aged; Orlistat; Pancreatitis; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2010 |
Sitagliptin: too many cases of pancreatitis.
Topics: Acute Disease; Humans; Hypoglycemic Agents; Pancreatitis; Pyrazines; Sitagliptin Phosphate; Triazoles | 2010 |
Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis.
Topics: Diabetes Mellitus, Type 2; Exenatide; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Pancreatitis; Peptides; Proportional Hazards Models; Pyrazines; Retrospective Studies; Sitagliptin Phosphate; Triazoles; Venoms | 2010 |
Protective effects of ligustrazine, kakonein and Panax notoginsenosides on multiple organs in rats with severe acute pancreatitis.
Topics: Acute Disease; Animals; Apoptosis; Disease Models, Animal; Drugs, Chinese Herbal; Ginsenosides; Isoflavones; Kidney; Liver; Male; Panax; Pancreas; Pancreatitis; Pyrazines; Rats; Rats, Sprague-Dawley; Saponins; Severity of Illness Index | 2010 |
Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies.
Topics: Adverse Drug Reaction Reporting Systems; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Odds Ratio; Pancreatic Neoplasms; Pancreatitis; Peptides; Pyrazines; Receptors, Glucagon; Risk Assessment; Risk Factors; Sitagliptin Phosphate; Thyroid Neoplasms; Triazoles; United States; United States Food and Drug Administration; Venoms | 2011 |
Journal withdraws article after complaints from drug manufacturers.
Topics: Diabetes Mellitus, Type 2; Drug Industry; Editorial Policies; Exenatide; Humans; Hypoglycemic Agents; Incretins; Pancreatitis; Peptides; Periodicals as Topic; Pyrazines; Sitagliptin Phosphate; Triazoles; Venoms | 2011 |
GLP-1-based therapies: the dilemma of uncertainty.
Topics: Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Pancreatic Neoplasms; Pancreatitis; Peptides; Pyrazines; Receptors, Glucagon; Risk Assessment; Risk Factors; Sitagliptin Phosphate; Thyroid Neoplasms; Triazoles; Uncertainty; Venoms | 2011 |
Pro- or anti-inflammatory properties of the adipokine dipeptidyl peptidase-4?
Topics: Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Pancreatic Neoplasms; Pancreatitis; Peptides; Pyrazines; Receptors, Glucagon; Thyroid Neoplasms; Triazoles; Venoms | 2011 |
Exenatide and sitagliptin: pancreatitis and pancreatic cancer. Harms on the rise.
Topics: Exenatide; Humans; Hypoglycemic Agents; Pancreatic Neoplasms; Pancreatitis; Peptides; Pyrazines; Sitagliptin Phosphate; Triazoles; Venoms | 2011 |
[The new antidiabetic agents in the firing line.... safety reasons or witch hunt?].
Topics: Animals; Breast Neoplasms; Calcitonin; Carcinoma, Medullary; Clinical Trials as Topic; Comorbidity; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Disease Susceptibility; Female; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Infections; Liraglutide; Pancreatitis; Pharmacovigilance; Pioglitazone; Pyrazines; Risk Assessment; Safety-Based Drug Withdrawals; Sitagliptin Phosphate; Species Specificity; Thiazolidinediones; Thyroid Neoplasms; Triazoles; Urinary Bladder Neoplasms | 2012 |
Detection of superoxide free radicals in rats with acute pancreatitis.
Topics: Acute Disease; Animals; Ceruletide; Free Radicals; Imidazoles; Kinetics; Luminescent Measurements; Male; Pancreas; Pancreatitis; Pyrazines; Rats; Rats, Wistar; Superoxide Dismutase; Superoxides | 1995 |
[Therapeutic effects and mechanisms of tetramethylpyrazine on lung injury in acute haemorrhagic necrotizing pancreatitis in rats].
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Free Radical Scavengers; Lipid Peroxides; Lung; Necrosis; Pancreatitis; Pyrazines; Random Allocation; Rats; Rats, Sprague-Dawley; Thromboxane B2 | 1993 |